Impairment in insulin secretion without changes in insulin resistance explains hyperglycemia in patients with acromegaly treated with pasireotide LAR
Objective: Pasireotide is a second-generation somatostatin receptor ligand (SRL) used for treating acromegaly. Its clinical use is limited by adverse effe cts on glucose homeostasis. The aim of this study was to evaluate longitudinal changes in beta-cell function and insulin sensitivity associated w...
Zapisane w:
| Główni autorzy: | , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Bioscientifica
2022-11-01
|
| Seria: | Endocrine Connections |
| Hasła przedmiotowe: | |
| Dostęp online: | https://ec.bioscientifica.com/view/journals/ec/11/12/EC-22-0296.xml |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|